Holmlin R. Erik 4

What Happened Erik R. Holmlin, President & CEO and a director of Bionano Genomics (BNGO), had 51 shares withheld by the company on Feb 17, 2026 to satisfy tax withholding obligations tied to an RSU settlement. The filing reports the shares at $1.10 each, for a notional value of about $56. This was a tax-withholding event (transaction code F), not an open-market sale or purchase.

Key Details

• Transaction date: 2026-02-17; reported on Form 4 filed 2026-02-18 (timely).
• Price: $1.10 per share; 51 shares withheld; total ≈ $56.
• Shares were withheld to cover tax on RSUs that vested on 2026-02-15 from an award granted 2023-02-15 (per footnote).
• The withheld shares were not issued to the reporting person (they were retained by the issuer to satisfy tax obligations).
• Shares owned after the transaction: not specified in the provided filing details.
• Transaction code: F (tax withholding).

Context This is a routine tax-withholding action tied to RSU vesting and does not represent a market sale or a deliberate purchase decision by the insider. Such withholdings are common when restricted stock units vest and generally do not signal management’s view of the company’s prospects.